1430. The Hidden Costs of Vancomycin Use During the Treatment of Staphylococcus aureus Bacteremia Concurrent with Acute Hematogenous Osteomyelitis

BACKGROUND: Current guidelines recommend the use of parenteral vancomycin for children with acute hematogenous osteomyelitis and concurrent Staphylococcus aureus bacteremia (SAB) due to Methicillin-Resistant Staphylococcus aureus (MRSA), despite vancomycin’s slow bactericidal activity. This study ex...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Open Forum Infect Dis
Main Authors: Ashley. Copley, Lawson, Sanchez, Maria J, Sue, Paul K, Lindsay, Eduardo A, Patel, Karisma, Tareen, Naureen G
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6808846/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1294
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki